K912817 is an FDA 510(k) clearance for the SOMNIMIC (R). Classified as Device, Sleep Assessment (product code LEL), Class II - Special Controls.
Submitted by Somnitec, Inc. (San Francisco, US). The FDA issued a Cleared decision on July 26, 1991 after a review of 66 days - a notably fast clearance cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5050 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Somnitec, Inc. devices